Genus

Industry

Digital & robotics, Seeds & genetics, Veterinary

Topics

GM traits & gene editing, Livestock & poultry production/genetics

Role

Distributor — “…perate in 30 countries with distribution to 50 additional markets. The company uses genomic selection to ident…”

Why it is bioeconomy

Genus is a global animal genetics company that uses biotechnology to improve livestock breeding, including the development of gene-edited PRRS-resistant pigs.

Products: ABS; PIC; Sexcel®; ABS Reproductive Management System (RMS)

Applications

Dairy production · Beef production · Pig production · Animal genetics · Livestock production

Customers & partners

Müller · ABP · Sainsbury’s · farmers

Products (website)

ABS — Focused on dairy and beef cattle · PIC — Focused on pigs · Sexcel® — Helps produce high-quality replacement heifers. · ABS Reproductive Management System (RMS) — Increases pregnancy rates.

Read from the company's own website: about · products · production · quality · rnd · leadership · contact · sustainability

Subsidiaries: Pig Improvement Company UK Limited · Genus Breeding Limited · PIC USA Inc. · ABS Global Inc. · Pig Improvement Company de Mexico, S. de R.L. de C.V. · PIC Ankang Agriculture Science and Technology Co., Ltd. · Liao Ning PIC Agriculture Science and Technology Company Limited · PIC (Shanghai) Agriculture Science and Technology Company Limited · Agroceres PIC Genética de Suinos Ltda.

• 2026-01 Latest status: On 31 January 2026, Genus formed a strategic porcine joint venture in China with Beijing Capital Agribusiness (BCA), resulting in the deconsolidation of its PIC China business. ↗ ↗ ↗
• 2026-09-10 Preliminary Results | Company Announcement | Investegate
  Genus reported FY26 results with strong growth and a strengthened balance sheet, including a 25% rise in adjusted operating profit to £116.0m and a £60m share buyback, plus a final dividend up 11%; they also completed a strategic porcine JV in China and expect …
• 2026-10-05 Transaction in Own Shares | Company Announcement | Investegate
  Genus PLC announced a buyback, purchasing 403,665 of its ordinary shares between 28 Sept and 2 Oct 2026 via JP Morgan, with intention to cancel, at prices generally between 2,108 and 2,210 pence per share and an average price around 2,153 pence.
• 2026-09-10 Genus lifts dividend, starts GBP60 million share buyback as profit up | Financial News
  Genus reported higher annual profit and launched a £60 million share buyback, while lifting the dividend; revenue declined slightly but one-off gains from a China stake sale boosted statutory pretax profit, signaling stronger cash generation and a solid …
• 2026-09-30 Issue of Equity | Company Announcement | Investegate
  Genus plc announces the issue of 450,000 new ordinary shares to its Employee Benefit Trust to satisfy share awards under approved plans, with these shares expected to be admitted to the London Stock Exchange on 6 October 2026 and ranking pari passu with …
• 2026-09-28 REG - Genus PLC - Admission to Trading — TradingView News
  Genus plc announces it has admitted 2,460 additional ordinary shares to trading on the London Stock Exchange Main Market, increasing total issued shares to 66,044,921. The allotment relates to employee share schemes and is fully fungible with existing shares.
• 2026-09-10 Genus FY26 Pretax Profit Rises
  Genus reports a strong fiscal 2026 with pretax profit of £310.5 million (up from £28.5 million) driven by a £204.1 million gain from disposing 51% of PIC China and a rise in IAS41 fair value of biological assets; adjusted pretax profit rose 35% to £100.2 …

Ownership & investors 9

Partners & deals 2

Similar companies

Axiom Global · GENES DIFFUSION · CRV · MASTERRIND GmbH · NUCLEUS · SUISAG · Pig Improvement Company (PIC) - Europe · Andrimner